Please provide your email address to receive an email when new articles are posted on . As the number of myopia cases increases globally, implementing effective therapies to slow the progression and ...
According to a secondary analysis of the 24- Month Myopia Outcome Study of Atropine in Children (MOSAIC) trial, 0.05% atropine eye drops were more effective in controlling myopia progression and axial ...
The United States is fast becoming a nearsighted nation: More than 40% of Americans have myopia, and the number is climbing fast, especially for children. Experts aren’t sure why, but they believe ...
SAN RAMON, Calif., October 6, 2021—CooperVision’s SightGlass Vision Business has revealed two-year clinical study data for its Diffusion Optics Technology ™ §, which is specifically designed to slow ...
Prior to this research, recent trials conducted primarily in East Asia showed a benefit from .01 percent atropine in slowing myopia. The randomized controlled trial, conducted by the Pediatric Eye ...
Background To evaluate the efficacy and safety of repeated low-level red-light (RLRL) therapy for controlling myopia ...
Child eye test and eye exam. Little girl having eye check-up, with phoropter. Doctor performs eye test for child. This story is part of a series on the current progression in Regenerative Medicine.
A study that focused on children aged 5 to 12 years who lived in the United States found no difference between atropine 0.01% and placebo in treating myopia progression. Atropine 0.01% was no more ...
Childhood myopia progression could be treated with low-dose atropine due to the safety and efficacy displayed in this study. The global prevalence of myopia was estimated to be 30% to 34% in 2020 and ...
In late September the U.S. Food and Drug Administration made an announcement that has the potential to positively impact tens of millions of kids for the rest of their lives. That’s because the FDA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback